Libtayo IV infusion 350mg

Libtayo IV infusion 350mg, manufactured by Regeneron Japan, contains Cemiplimab (genetical recombination). This monoclonal antibody is a PD-1 blocking antibody, an immune checkpoint inhibitor used to treat certain cancers by enhancing the body’s anti-tumor immune response. It is supplied as 350mg in 7mL per bottle, with YJ code 4291466A1024.